rxstat › Shortages › Sertraline
Sertraline shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Sertraline products are in shortage in Canada (1 of 37 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
In shortage since
Mar 17, 2017
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageACT SERTRALINE
25MG · CAPSULE · ACTAVIS PHARMA COMPANY
DIN 02287390 · since Mar 17, 2017, no end estimate · Disruption of the manufacture of the drug.
AnticipatedZOLOFT
100MG · CAPSULE · BGP PHARMA ULC
DIN 01962779 · Disruption of the manufacture of the drug.
AnticipatedZOLOFT
25MG · CAPSULE · BGP PHARMA ULC
DIN 02132702 · Disruption of the manufacture of the drug.
AnticipatedZOLOFT
50MG · CAPSULE · BGP PHARMA ULC
DIN 01962817 · Disruption of the manufacture of the drug.
AnticipatedSERTRALINE
100MG · CAPSULE · SANIS HEALTH INC
DIN 02353547 · Other (Please describe in comments)
ResolvedTEVA-SERTRALINE
100MG · CAPSULE · TEVA CANADA LIMITED
DIN 02240481 · ended Apr 1, 2026 · Disruption of the manufacture of the drug.
ResolvedTEVA-SERTRALINE
50MG · CAPSULE · TEVA CANADA LIMITED
DIN 02240484 · ended Apr 1, 2026 · Disruption of the manufacture of the drug.
ResolvedSERTRALINE
25MG · CAPSULE · SANIS HEALTH INC
DIN 02353520 · ended Mar 4, 2026 · Disruption of the manufacture of the drug.
ResolvedTEVA-SERTRALINE
50MG · CAPSULE · TEVA CANADA LIMITED
DIN 02240484 · ended Feb 4, 2026 · Disruption of the manufacture of the drug.
ResolvedTEVA-SERTRALINE
100MG · CAPSULE · TEVA CANADA LIMITED
DIN 02240481 · ended Jan 21, 2026 · Disruption of the manufacture of the drug.
ResolvedTEVA-SERTRALINE
25MG · CAPSULE · TEVA CANADA LIMITED
DIN 02240485 · ended Jan 21, 2026 · Disruption of the manufacture of the drug.
ResolvedSERTRALINE
100MG · CAPSULE · SANIS HEALTH INC
DIN 02353547 · ended Aug 19, 2025 · Disruption of the manufacture of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Sertraline is currently affected by an active shortage report filed with Health Canada by ACTAVIS PHARMA COMPANY.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Sertraline is classified under “ANTIDEPRESSANTS” (ATC N06AB).
Recent changes
Common questions
When will Sertraline be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Sertraline in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.